Delivery Order SPE2DP24D0004-SPE2DP24F7882
Award Date
9/12/24
Potential Completion Date
9/27/24
Potential Value
$3.8K
Federal Agency
Medical Supply Chain
Awardee
Seqirus USA Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Summit, NJ 07901, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DP16D0005|0001, is for the delivery of influenza virus vaccines. The contract was awarded to Seqirus USA Inc., a global biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies. The contract is a firm-fixed-price delivery order with a ceiling value of $10,003,042.50 and a performance period ending on September 30, 2016. The contract was awarded by the...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company, for the provision of influenza virus vaccines. The contract, valued at $12,072,680.00, has an ultimate completion date of October 13, 2023. Seqirus USA Inc. is a global leader in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies. The company holds several...
This is a delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines. The contract has a ceiling value of $2,908,197.50 and an ultimate completion date of October 13, 2023. It is a firm fixed-price contract for the delivery of influenza virus vaccines. The contract is not set aside for any specific type of...
This federal contract award is for the delivery of influenza virus vaccines to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DOD). The contract was awarded to Seqirus USA Inc., a global biotechnology company that specializes in the development and delivery of influenza vaccines. The contract is a Firm Fixed Price Delivery Order with a potential value of $17,728,962.81 and a completion date of November 16, 2020. This contract was not set aside...
Seqirus USA Inc., through its Seqirus Usa, Inc. Division, has been awarded a $2,533,765.00 firm fixed price delivery order contract (SPE2DP24D0004|SPE2DP24F3311) by the Defense Logistics Agency Troop Support Medical to provide influenza virus vaccines. This contract has an ultimate completion date of September 27, 2024 and is not designated as a set-aside. Seqirus is a global biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to various...
The U.S. Department of Defense's Medical Supply Chain (Defense Logistics Agency) awarded a $204,000.00 firm-fixed-price delivery order contract to Seqirus USA Inc. to provide influenza virus vaccines. This contract, awarded on October 23, 2024, has an ultimate completion date of November 4, 2024. Seqirus USA Inc., a foreign-owned, for-profit manufacturer of goods, has been awarded multiple indefinite delivery contracts (IDCs) with the Department of Veterans Affairs, Defense Logistics Agency, and...
This federal contract award, SPE2DP16M0735, was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines. The $124,772.50 firm-fixed-price purchase order is for the delivery of influenza virus vaccines, with an ultimate completion date of October 3, 2016. The contract does not have a set-aside designation. Seqirus USA Inc., through its Seqirus Usa, Inc. division, is known for producing a...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Seqirus USA Inc. for the delivery of influenza virus vaccines. The contract has a ceiling value of $259,000.00 and a period of performance ending on November 30, 2015. Seqirus USA Inc. is a global biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines to various federal government agencies. This contract supports annual flu...
This federal contract award, SPE2DP15D0004|0006, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines. The $142,200.00 firm-fixed-price delivery order is for the supply of influenza virus vaccines, with an ultimate completion date of November 30, 2015. The contract is not designated as a set-aside. Seqirus USA Inc. has been awarded numerous similar federal contracts to supply influenza vaccines...
This federal contract award is for the delivery of flu vaccines by Seqirus USA Inc., a global biotechnology company, to various U.S. government agencies including the Department of Defense, Department of Veterans Affairs, Department of Health and Human Services, and Department of Justice. The contract, valued at $1,351,500.00, is a Firm Fixed Price Purchase Order with a completion date of July 7, 2019. The contract is not designated as a set-aside. Seqirus USA Inc. has been awarded numerous...